Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sunitinib (sutent) (1 trial)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Trials (1 total)
Trial APIs (1 total)